MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$1,174K
EPS
-$0.04
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Research and development
5,814
9,643*
14,391
21,196
General and administrative
5,138
4,797*
4,775
5,880
Total operating expenses
10,952
14,439
19,166
27,076
Loss from operations
-10,952
-14,439*
-19,166
-27,076
Interest income
164
715*
342
-
Change in fair value of warrant liability
-9,640
-2,231*
-2,099
-
Other expense, net
-26
3,846*
-2,011
-
Total other income, net
9,778
6,792*
430
-
Net loss and comprehensive loss
-1,174
-7,647
-18,736
-26,700
Basic EPS
-0.04
-0.299
-1.13
-1.74
Diluted EPS
-0.04
-0.299
-1.13
-1.74
Basic Average Shares
28,671,819
25,534,584
16,635,784
15,333,962
Diluted Average Shares
28,671,819
25,534,584
16,635,784
15,333,962
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Change in fair value of
warrant liability
-$9,640K
Interest income
$164K
Net loss and
comprehensive loss
-$1,174K
Total other income,
net
$9,778K
Other expense, net
-$26K
Loss from operations
-$10,952K
Total operating
expenses
$10,952K
Research and development
$5,814K
General and
administrative
$5,138K
Buy us a coffee
Jasper Therapeutics, Inc. (JSPRW)
Jasper Therapeutics, Inc. (JSPRW)